This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
By This Author:
« Back
Page 1 of 24

Equity Deals Could Heat Up Rivalries (RealMoney.com $)

By David Sterman

A flurry of capital raises highlights the changing outlook for a number of industries.

03:59PM 05/12/09

Beyond the Lede: Playing the Economic Data (RealMoney.com $)

By David Sterman

Changing monthly data portend a shift for staffers and shippers, and the rig-cutting cycle nears an end.

02:30PM 05/11/09

A Brutal Month for Shorts (RealMoney.com $)

By David Sterman

But if the rally cools, some of these ideas may move still lower.

10:03AM 05/08/09

Ford May Offer a Bumpy Ride Higher (RealMoney.com $)

By David Sterman

The newly appreciated stock will have to contend with the industry's inventory issues.

02:29PM 05/06/09

Kindle Could Singe Barnes & Noble (RealMoney.com $)

By David Sterman

The e-reader has only a fringe following, but it could slow the bookseller's rebound.

12:05PM 05/05/09

Beyond the Lede: Celgene Takes Its Knocks (RealMoney.com $)

By David Sterman

The company leaves its Revlimid target set too high, setting it up for disappointment.

01:31PM 05/04/09

ScreenShot: The Hunt for Low P/Es (RealMoney.com $)

By David Sterman

Although they're getting harder to find, there are still cheap stocks heading to the upside.

01:16PM 05/01/09

A Sneak Peek at Second-Quarter GDP (RealMoney.com $)

By David Sterman

The coming economic calendar will give clues to a possible snapback in the economy.

02:59PM 04/29/09

First Solar Pulls Away From the Pack (RealMoney.com $)

By David Sterman

Be careful, though - the company's mergers and partnerships come with risk.

02:46PM 04/28/09

No Surprises From Bristol-Myers Squibb (RealMoney.com $)

By David Sterman

The focus was on new drugs under development and bringing them to market.

01:05PM 04/28/09

« Back
Page 1 of 24

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs